Provided by Tiger Fintech (Singapore) Pte. Ltd.

Finch Therapeutics Group, Inc.

13.05
-0.1200-0.91%
Volume:1.01K
Turnover:13.25K
Market Cap:20.96M
PE:-1.48
High:13.25
Open:13.25
Low:13.00
Close:13.17
Loading ...

Company Profile

Company Name:
Finch Therapeutics Group, Inc.
Exchange:
PINK LIMITED
Establishment Date:
2014
Employees:
1
Office Location:
75 State Street,Suite 100,Boston,Massachusetts,United States
Zip Code:
02109
Fax:
- -
Introduction:
Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company develops FIN-211, a microbiome candidate designed to address the gastrointestinal and behavioral symptoms of autism spectrum disorder; and FIN-524, FIN-525, and other microbiome product candidates for inflammatory bowel disease. The company has collaboration and license agreements with Takeda Pharmaceutical Company Limited; Skysong Innovations LLC; and University of Minnesota. Finch Therapeutics Group, Inc. was incorporated in 2014 and is based in Somerville, Massachusetts.